Geroderma osteodysplastica
|
0.770 |
Biomarker
|
disease |
BEFREE |
Our results therefore identify GORAB as a COPI scaffolding factor, and support the view that defective protein glycosylation is a major disease mechanism in gerodermia osteodysplastica.
|
30631079 |
2019 |
Bone Diseases
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Here, we identify GORAB, the protein mutated in the skin and bone disorder gerodermia osteodysplastica, as a component of the COPI machinery.
|
30631079 |
2019 |
Geroderma osteodysplastica
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
Using whole exome sequencing, we identified novel compound heterozygous nonsense mutations in the GORAB in a GO patient.
|
28807865 |
2017 |
Geroderma osteodysplastica
|
0.770 |
Biomarker
|
disease |
BEFREE |
A conditional mouse model of GO (Gorab<sup>Prx1</sup>) was generated in which the Gorab gene was deleted in long bones.
|
29108851 |
2017 |
Osteoporosis
|
0.410 |
GeneticVariation
|
disease |
BEFREE |
Gerodermia osteodysplastica (GO) is a segmental progeroid disorder caused by loss-of-function mutations in the GORAB gene, associated with early onset osteoporosis and bone fragility.
|
29108851 |
2017 |
Progeroid facial appearance
|
0.400 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Novel compound heterozygous mutations identified by whole exome sequencing in a Japanese patient with geroderma osteodysplastica.
|
28807865 |
2017 |
Cutis Laxa
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
A de novo 1q23.3-q24.2 deletion combined with a GORAB missense mutation causes a distinctive phenotype with cutis laxa.
|
27604556 |
2017 |
Other alopecia
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk.
|
29146897 |
2017 |
Androgenetic Alopecia
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk.
|
29146897 |
2017 |
Alopecia, Androgenetic, 3
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk.
|
29146897 |
2017 |
Alopecia, Androgenetic, 2
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk.
|
29146897 |
2017 |
Alopecia, Androgenetic, 1
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk.
|
29146897 |
2017 |
Alopecia, Male Pattern
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk.
|
29146897 |
2017 |
Geroderma osteodysplastica
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
Two GORAB missense mutations identified in gerodermia osteodysplastica patients fall within this IGRAB domain.
|
26000619 |
2015 |
Geroderma osteodysplastica
|
0.770 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Two GORAB missense mutations identified in gerodermia osteodysplastica patients fall within this IGRAB domain.
|
26000619 |
2015 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.010 |
Biomarker
|
disease |
BEFREE |
Common variants in or near ZNRF1, COLEC12, SCYL1BP1 and API5 are associated with diabetic retinopathy in Chinese patients with type 2 diabetes.
|
25819896 |
2015 |
Diabetic Retinopathy
|
0.010 |
Biomarker
|
disease |
BEFREE |
Common variants in or near ZNRF1, COLEC12, SCYL1BP1 and API5 are associated with diabetic retinopathy in Chinese patients with type 2 diabetes.
|
25819896 |
2015 |
Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Functional assays found that reintroduction of SCYL1BP1 into HCC cell lines significantly inhibited cell proliferation, foci formation, colony formation in soft agar and tumor formation in nude mice, suggesting the strong tumor-suppressive function of SCYL1BP1 in HCC progression.
|
22570270 |
2012 |
Liver carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, SCYL1BP1 was found to be frequently downregulated in HCC clinical specimens compared to their paired non-tumor tissues by immunohistochemical staining.
|
22570270 |
2012 |
Cutis laxa, autosomal recessive
|
0.010 |
Biomarker
|
disease |
BEFREE |
Investigation of brefeldin A-induced Golgi collapse in dermal fibroblasts as well as in HeLa cells deficient for ATP6V0A2 revealed a delay, which was absent in cells deficient for the ARCL-associated proteins GORAB or PYCR1.
|
22773132 |
2012 |
Geroderma osteodysplastica
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
Although the disease resulting from recessive mutations in that gene has been recently designated ARCL2B, some clinical features, such as prognathism, elongated and lax face, osteopenia and limitation of skin wrinkling to the dorsum of hands and feet, in the patients reported here as well as in others reported with PYCR1 mutations, are generally more common in geroderma osteodysplasticum resulting from recessive GORAB mutations.
|
21204221 |
2011 |
Osteopenia
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
While the patients with GORAB mutations have severe osteopenia, the patients with PYCR1 mutations have severe mental retardation.
|
21204221 |
2011 |
Geroderma osteodysplastica
|
0.770 |
Biomarker
|
disease |
BEFREE |
Our study, therefore, supplements the limited available data on SCYL1BP1 and further establishes deficiency of this recently described golgin as the only known cause of GO.
|
19681135 |
2009 |
Geroderma osteodysplastica
|
0.770 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Our study, therefore, supplements the limited available data on SCYL1BP1 and further establishes deficiency of this recently described golgin as the only known cause of GO.
|
19681135 |
2009 |
Geroderma osteodysplastica
|
0.770 |
GermlineCausalMutation
|
disease |
ORPHANET |
Here we demonstrate that gerodermia osteodysplastica is caused by loss-of-function mutations in SCYL1BP1, which is highly expressed in skin and osteoblasts.
|
18997784 |
2008 |